Viridian Therapeutics, Inc.
A biotechnology company developing novel medicines using a proprietary monoclonal antibody discovery and optimization platform. The company is developing multiple product candidates for the treatment of thyroid eye disease, a debilitating autoimmune disease that causes bulging, redness, swelling and potential blindness. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 94 |
Founded | 2006 |
Financials | |
|---|---|
Market Capitalization | 886.49M |
Revenue | 0.29M |
Operating Income | -237.87M |
Operating Margin | -82595.14% |
Net Income | -218.12M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 5127 / 5373 |
Sector : Healthcare | 1055 / 1144 |
Industry : Biotechnology | 583 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2550 / 5565 |
Sector : Healthcare | 331 / 1182 |
Industry : Biotechnology | 136 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 5115 / 5436 |
Sector : Healthcare | 1060 / 1164 |
Industry : Biotechnology | 592 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4073 / 5330 |
Sector : Healthcare | 651 / 1174 |
Industry : Biotechnology | 261 / 667 |